Introduction {#s1}
============

Colorectal cancer is one of the most common cancers worldwide [@pone.0059628-Center1], [@pone.0059628-Rim1]. The incidence of colorectal cancer has increased in most Asian countries, including Korea [@pone.0059628-Sung1].

A number of risk factors are associated with colorectal cancer, including dietary factors [@pone.0059628-Byers1]. Previous studies have evaluated the associations between daily calcium or dairy food intake and colorectal cancer risk [@pone.0059628-Wu1], [@pone.0059628-Cho1], [@pone.0059628-Larsson1], [@pone.0059628-Dai1], [@pone.0059628-Park1], [@pone.0059628-Huncharek1], [@pone.0059628-Shin1]. The results of those studies were inconsistent; however, a pooled analysis of 10 cohort studies [@pone.0059628-Cho1] and a meta-analysis of 60 observational studies [@pone.0059628-Huncharek1] consistently demonstrated positive associations between high calcium intake and reduced colorectal cancer risk.

A number of previous studies focused on the effects of genetic polymorphisms related to nutrition metabolism, such as *methylenetetrahydrofolate reductase* (*MTHFR*) [@pone.0059628-Taioli1], [@pone.0059628-Lee1], *methionine synthase* (*MTR*) [@pone.0059628-Levine1], [@pone.0059628-Jokic1], and *vitamin D receptor* (*VDR*) gene variants [@pone.0059628-Wong1], [@pone.0059628-Slattery1], [@pone.0059628-Slattery2], [@pone.0059628-Park2], [@pone.0059628-Slattery3], [@pone.0059628-Slattery4]. The *MTHFR* 677TT and 1298CC polymorphisms seem to be associated with a reduced risk of CRC [@pone.0059628-Taioli1], [@pone.0059628-Lee1]. Additionally, a tagSNP in the *MTR* (rs4659744) was significantly associated with reduced colorectal cancer risk [@pone.0059628-Levine1]. Recently, the effects of the *calcium-sensing receptor* (*CASR)* gene on colorectal cancer have also garnered attention [@pone.0059628-Dong1], [@pone.0059628-Speer1], [@pone.0059628-Jacobs1], [@pone.0059628-Jenab1]. Previous extracellular experiments have reported that *CASR* expression is involved in colorectal carcinoma differentiation through promoting E-cadherin expression and suppressing beta-catenin/TCF activation. [@pone.0059628-Kallay1], [@pone.0059628-Chakrabarty1]. Several studies have also evaluated gene-environment (*CASR* and calcium intake) interactions associated with colorectal cancer risk [@pone.0059628-Dong1], [@pone.0059628-Jenab1]. However, the role of *CASR* and calcium intake in colorectal cancer incidence is not fully understood due to the relatively small sample sizes and inconclusive results of these studies.

This case-control study aimed to explore the associations between *CASR* variants with daily calcium intake and colorectal cancer risk in Korea. We examined the main effects of the *CASR* on colorectal cancer by sex and cancer sites. Then, we evaluated possible gene-environment interactions between *CASR* polymorphisms and daily calcium intake in the context of colorectal cancer risk.

Materials and Methods {#s2}
=====================

Study Participants and Data Collection {#s2a}
--------------------------------------

All participants provided written informed consent to participation, and the study protocol was approved by the Institutional Review Board of the National Cancer Center. Eligible colorectal cancer patients were recruited from the Center for Colorectal Cancer, National Cancer Center in Korea from August 2010 to December 2011. Among 702 eligible colorectal cancer patients, 671 patients were contacted, and 554 agreed to participate in the study. Patients from whom blood samples were not obtained or who did not complete a structured questionnaire were excluded from the analysis. As a result, 420 colorectal cancer patients remained in the final analysis. Eligible controls were recruited from March 2010 to August 2011 from among patients who visited the Center for Early Detection and Prevention of the National Cancer Center, Korea, for regular health examination. Among 4,514 eligible controls, 3,687 agreed to participate in the study; 1,014 participants who did not complete a self-administered questionnaire were excluded. The remaining 2,673 participants were 1∶2 matched with 420 colorectal cancer patients by sex and 5-year age range, and 960 subjects were selected. Among these 960 controls, 145 whose blood samples were not obtained were excluded. Thus, information from 1,235 participants (420 cases and 815 controls) was considered in the final analysis. Information on total energy and calcium intake were available from 1,188 of these subjects for inclusion in the analyses to evaluate the joint effects of calcium intake and *CASR* polymorphisms on colorectal cancer.

Information on subject age, education level, smoking and alcohol drinking habits, household income, menopausal status (women only) and history of hormone replacement therapy (post-menopausal women only) were obtained by questionnaire. The cancer site was classified as proximal colon, distal colon, or rectum for each patient. Subject height and weight were measured, and body mass index (BMI) was calculated.

The regular dietary intake of each study participant was recorded using a semi-quantitative food frequency questionnaire (SQFFQ). The reliability and validity of the FFQ was demonstrated in a previous report [@pone.0059628-Ahn1]. The FFQ consisted of 103 food items, and participants were asked to report the average frequencies and portion sizes of the foods that they ate during the previous year. For each of the 103 food items, nutrient quantity per 100 g was measured and converted to daily nutrient intake.

*CASR* Genotyping (TaqMan Assay) {#s2b}
--------------------------------

Based on the literature, four SNPs of *CASR* that showed an association with colorectal cancer risk were selected for analysis [@pone.0059628-Dong1], [@pone.0059628-Jacobs1]. The genotyping of *CASR* polymorphism (rs10934578, rs12485716, rs2270916, rs4678174) was screened using the TaqMan fluorogenic 5′ nuclease assay (ABI, Foster City, CA, USA). The polymerase chain reaction (PCR) was performed in a 5 µl reaction containing 10 ng genomic DNA, 2.5 µl TaqMan Universal PCR Master Mix, and 0.13 µl of 20X Assay Mix (Assay ID C\_\_\_2684958_10). The thermal cycling conditions were as follows: 50°C for 2 min to activate the uracil N-glycosylase and to prevent carry-over contamination, 95°C for 10 min to activate the DNA polymerase, followed by 45 cycles of 95°C for 15 s and 60°C for 1 min. All PCR assays were performed in 384-well plates in a Dual 384-Well GeneAmp PCR System 9700 (ABI, Foster City, CA, USA), and the endpoint fluorescent readings were taken by an ABI PRISM 7900 HT Sequence Detection System (ABI, Foster City, CA, USA). Duplicate samples and negative controls were included to ensure genotyping accuracy.

Statistical Analysis {#s2c}
--------------------

To compare general characteristics between cases and controls, chi-square tests and Student's t-tests were performed. Chi-square tests were employed to explore the distributions of each genotype between the calcium intake groups. First, we performed separate chi-square analyses for each calcium intake group (low intake group and high intake group). The cut-off point for median calcium intake was based on the distribution in the control group. Participants whose calcium intake fell below the median value were classified in the low calcium intake group; the remaining participants were classified in the high calcium intake group. Then, Mantel-Haenszel chi-square tests were used to evaluate combined statistics. We investigated the main effects of *CASR* on colorectal cancer according to genetic inheritance models, including additive, dominant, and recessive models. To investigate the association between *CASR* polymorphisms and colorectal cancer risk by cancer site, a polytomous logistic regression model was used. We used logistic regression models to calculate odds ratios for colorectal cancer risk. Interaction p-values were calculated using the likelihood ratios from the chi-square distribution function. SAS version 9.1 (SAS Institute Inc., Cary, NC) was used for all analyses.

Results {#s3}
=======

The basic characteristics and demographic descriptions of the study participants are presented in [Table 1](#pone-0059628-t001){ref-type="table"}. Among the male participants, differences in age, height, weight, BMI, alcohol drinking status, education, and household income were observed between colorectal cancer patients and controls. In female subjects, differences in height, BMI, smoking status, alcohol status, education level, and household income were observed between patients with different colorectal cancer status. It also appeared that among the post-menopausal women, colorectal cancer patients took more HRT than did control subjects (p = 0.019, data not shown).

10.1371/journal.pone.0059628.t001

###### Study participant characteristics, mean (standard deviation).

![](pone.0059628.t001){#pone-0059628-t001-1}

                                                                                   Male              p          Female          p                          
  ----------------------------------------------- -------------------------- ---------------- ---------------- --------- ---------------- ---------------- ---------
  Age groups, N (%)                                         30∼39                11 (3.9)         18 (3.5)      \<0.001      9 (6.5)          26 (8.7)       0.391
                                                            40∼49               52 (18.4)        119 (23.1)                 22 (15.9)        48 (16.0)     
                                                            50∼59               90 (31.9)        219 (42.5)                 50 (36.2)        126 (42.0)    
                                                             60∼                129 (45.7)       159 (30.9)                 57 (41.3)        100 (33.3)    
  Height (cm)                                                                  168.1 (6.1)      169.8 (5.9)     \<0.001    155.3 (6.1)      157.6 (4.7)     \<0.001
  Weight (kg)                                                                   66.6 (9.7)      70.4 (10.6)     \<0.001     57.0 (8.7)       57.6 (8.7)      0.450
  BMI (kg/m2)                                                                   23.6 (2.9)       24.3 (2.7)     \<0.001     24.3 (3.7)       23.1 (2.5)      0.061
  Smoking status,                                           never               65 (23.2)        104 (20.2)      0.304      123 (89.1)       293 (98.0)      0.001
  N (%)                                                     former              130 (46.3)       267 (52.0)                  5 (3.6)          4 (1.3)      
                                                           current              86 (30.6)        143 (27.8)                  10 (7.3)         2 (0.7)      
  Alcohol drinking,                                         never               48 (17.1)        85 (16.5)       0.002      82 (59.4)        189 (63.2)      0.024
  N (%)                                                     former              64 (22.8)        69 (13.4)                  21 (15.2)         21 (7.0)     
                                                           current              169 (60.1)       360 (70.0)                 35 (25.4)        89 (30.0)     
  Education,                                       elementry school or less     40 (14.2)         27 (5.5)      \<0.001     51 (37.0)         24 (8.6)      \<0.001
  N (%)                                                 middle school           52 (18.5)         41 (8.4)                  25 (18.1)         24 (8.6)     
                                                         high school            98 (34.9)        156 (31.8)                 39 (28.3)        142 (50.7)    
                                                        collge or more          91 (32.4)        266 (54.3)                 23 (16.7)        90 (32.1)     
  Monthly income                                             ∼100               44 (15.7)         24 (5.3)      \<0.001     33 (24.0)         16 (6.4)      \<0.001
  (Won), N (%)                                             100--200             71 (25.3)        70 (15.4)                  22 (15.9)        42 (16.8)     
                                                           200--400             101 (35.9)       210 (46.3)                 53 (38.4)        102 (40.8)    
                                                             400∼               65 (23.1)        150 (33.0)                 30 (21.7)        90 (36.0)     
  Post-menopausal, N (%)                                                                                                    101 (73.2)       212 (70.7)      0.587
  HRT (post-menopausal women only), N (%)                   never                                                            4 (4.0)          20 (9.8)       0.019
                                                            former                                                          14 (14.0)        48 (23.4)     
                                                           current                                                          82 (82.0)        137 (66.8)    
  Total energy intake (kcal/day)                                              2131.5 (484.1)   1790.9 (565.5)   \<0.001   1805.0 (518.9)   1709.9 (626.1)    0.112
  Total calcium intake (mg/day)                                               438.8 (178.0)    440.3 (243.4)     0.922    444.2 (210.5)     543.9(360.8)     0.001
  Energy adjusted total calcium intake (mg/day)                               382.6 (128.9)    451.3 (204.0)    \<0.001   452.9 (169.7)     572.2(251.5)    \<0.001

[Table 1](#pone-0059628-t001){ref-type="table"} also shows the subjects' total energy intake, total calcium intake, and energy-adjusted total calcium intake. Among all subjects, the total energy intake was higher for colorectal cancer patients, whereas energy-adjusted total calcium intake was higher for the control group.

All 4 SNPs were in Hardy-Weinberg equilibrium and consistent with the genotype distribution in the Asian population in HapMap. The association between *CASR* polymorphisms and colorectal cancer are presented in [Table 2](#pone-0059628-t002){ref-type="table"}, subdivided according to genetic inheritance mode. No SNPs showed significant effects on colorectal cancer after adjusting for age, sex, smoking status, alcohol drinking status, and monthly household income. Similarly, we found no associations between *CASR* variants and colorectal cancer site, i.e., proximal colon, distal colon, and rectum ([Table 3](#pone-0059628-t003){ref-type="table"}).

10.1371/journal.pone.0059628.t002

###### The associations between *CASR* polymorphisms and colorectal cancer risk.

![](pone.0059628.t002){#pone-0059628-t002-2}

  Genetic inheritance mode    SNPs (n cases/n controls)   OR[a](#nt102){ref-type="table-fn"}   95% CI  
  -------------------------- --------------------------- ------------------------------------ -------- ------------
  Additive                           rs10934578                      TT (85/158)                       
                                                                     GT (203/385)               1.13    0.84--1.52
                                                                     GG (124/254)               1.12    0.78--1.62
                                     rs12485716                      GG (80/149)                       
                                                                     GA (199/396)               1.03    0.78--1.38
                                                                     AA (135/266)               1.09    0.76--1.58
                                      rs2270916                      TT (77/132)                       
                                                                     CT (192/389)               0.98    0.74--1.31
                                                                     CC (149/291)               1.14    0.79--1.65
                                      rs4678174                      TT (87/160)                       
                                                                     CT (202/387)               1.18    0.88--1.58
                                                                     CC (122/260)               1.17    0.82--1.69
  Dominant                           rs10934578                      GG (85/158)                       
                                                                   TT+GT (327/639)              1.04    0.76--1.43
                                     rs12485716                      AA (80/149)                       
                                                                   GG+GA (334/662)              1.07    0.77--1.48
                                      rs2270916                      CC (77/132)                       
                                                                   TT+CT (341/680)              1.15    0.83--1.61
                                      rs4678174                      CC (87/160)                       
                                                                   TT+CT (324/647)              1.07    0.78--1.46
  Recessive                          rs10934578                      TT (124/254)                      
                                                                   GG+GT (288/543)              0.89    0.67--1.17
                                     rs12485716                      GG (135/266)                      
                                                                   AA+GA (279/545)              0.95    0.73--1.25
                                      rs2270916                      TT (149/291)                      
                                                                   CC+CT (269/521)              0.98    0.75--1.27
                                      rs4678174                      TT (122/260)                      
                                                                   CC+CT (289/547)              0.66    0.44--1.01

Abbreviations: SNP = single nucleotide polymorphism; OR = odds ratio; CI = confidence interval.

Odds ratios adjusted for age (categorical), sex, smoking, alcohol, and monthly household income.

10.1371/journal.pone.0059628.t003

###### The associations between *CASR* polymorphisms and colorectal cancer risk by cancer site.

![](pone.0059628.t003){#pone-0059628-t003-3}

  Genetic inheritance mode       SNPs      Proximal colon   Distal colon     Rectum                               
  -------------------------- ------------ ---------------- -------------- ------------ ------ ------------ ------ ------------
  Additive                    rs10934578         TT                                                               
                                                 GT             1.31       0.70--2.44   1.30   0.83--2.03   0.75   0.51--1.09
                                                 GG             0.96       0.42--2.18   1.30   0.76--2.24   0.76   0.47--1.23
                              rs12485716         GG                                                               
                                                 GA             1.10       0.61--1.99   1.22   0.79--1.90   0.71   0.49--1.03
                                                 AA             1.00       0.46--2.16   1.35   0.79--2.32   0.74   0.46--1.20
                              rs2270916          TT                                                               
                                                 CT             1.07       0.60--1.91   1.12   0.73--1.71   0.75   0.52--1.09
                                                 CC             1.00       0.46--2.19   1.36   0.80--2.31   0.87   0.54--1.41
                              rs4678174          TT                                                               
                                                 CT             1.38       0.73--2.62   1.29   0.82--2.00   0.81   0.55--1.18
                                                 CC             1.13       0.51--2.54   1.23   0.72--2.12   0.80   0.50--1.29
  Dominant                    rs10934578         GG                                                               
                                               TT+GT            0.81       0.40--1.63   1.10   0.70--1.73   0.90   0.59--1.38
                              rs12485716         AA                                                               
                                               GG+GA            0.94       0.48--1.86   1.19   0.75--1.89   0.89   0.58--1.39
                              rs2270916          CC                                                               
                                               TT+CT            0.96       0.47--1.95   1.27   0.80--2.03   1.02   0.65--1.58
                              rs4678174          CC                                                               
                                               TT+CT            0.92       0.47--1.82   1.05   0.67--1.66   0.91   0.60--1.39
  Recessive                   rs10934578         TT                                                               
                                               GG+GT            0.83       0.46--1.51   0.77   0.50--1.17   1.33   0.94--1.89
                              rs12485716         GG                                                               
                                               AA+GA            0.93       0.53--1.64   0.79   0.52--1.20   1.39   0.98--1.97
                              rs2270916          TT                                                               
                                               CC+CT            0.95       0.55--1.65   0.85   0.57--1.26   1.28   0.91--1.80
                              rs4678174          TT                                                               
                                               CC+CT            0.76       0.42--1.41   0.79   0.52--1.20   1.24   0.87--1.76

Abbreviations: SNP = single nucleotide polymorphism; OR = odds ratio; CI = confidence interval.

Odds ratios were obtained from polytomous regression model; adjusted for age (categorical), sex, smoking, alcohol, and monthly household income.

[Table 4](#pone-0059628-t004){ref-type="table"} shows the interaction effects between *CASR* genotypes and calcium intake. We did not find any overall interaction effects in our analyses. However, all 4 of the *CASR* polymorphisms investigated showed significant odds ratios for association with colorectal cancer risk in the low calcium intake group compared with the high calcium intake group after adjusting for age, sex, smoking status, alcohol drinking, and monthly household income. For rs2270916, participants who had the CC genotype and low calcium intake showed the highest colorectal cancer risk among all subjects (OR = 2.11, 95% CI = 1.27--3.51), demonstrating an increased risk in comparison to the high calcium intake group with the same genotype.

10.1371/journal.pone.0059628.t004

###### The interaction effects between energy-adjusted daily calcium intake and *CASR* polymorphisms.

![](pone.0059628.t004){#pone-0059628-t004-4}

  SNP           OR[a](#nt106){ref-type="table-fn"} (95% CI)   p for interaction                      
  ------------ --------------------------------------------- ------------------- ------------------- -------
  rs10934578                        TT                        1.77 (1.14--2.77)           1           0.295
                                    GT                        1.92 (1.28--2.89)   0.99 (0.65--1.51)  
                                    GG                        1.84 (1.12--3.00)   0.88 (0.50--1.56)  
  rs12485716                        GG                        1.90 (1.23--2.95)           1           0.769
                                    GA                        1.72 (1.15--3.58)   0.94 (0.62--1.44)  
                                    AA                        1.89 (1.14--3.11)   0.85 (0.47--1.61)  
  rs2270916                         TT                        2.01 (1.31--3.09)           1           0.375
                                    CT                        1.83 (1.22--2.75)   0.97 (0.63--1.48)  
                                    CC                        2.11 (1.27--3.51)   1.02 (0.57--1.83)  
  rs4678174                         TT                        1.64 (1.05--2.56)           1           0.883
                                    CT                        1.83 (1.22--2.76)   0.95 (0.62--1.44)  
                                    CC                        1.73 (1.06--2.83)   0.84 (0.48--1.49)  

Abbreviations: SNP = single nucleotide polymorphism; OR = odds ratio.

Adjusted for age (categorical), sex, smoking, alcohol, and monthly household income.

criteria for low and high calcium intakes was 417.06 mg per a day.

Discussion {#s4}
==========

In this study, we aimed to explore the effects of *CASR* polymorphisms and calcium intake on colorectal cancer. To our knowledge, few studies have focused on gene-environment interactions between *CASR* variants and dietary calcium intake with respect to colorectal cancer. This is the first study that demonstrates the effects of *CASR* gene polymorphisms and *CASR*-calcium intake interactions in a Korean population with a substantial number of subjects.

A number of previous studies have proposed that calcium may protect against colorectal cancer risk by binding fatty acids and secondary bile acids in the colonic lumen [@pone.0059628-Newmark1], [@pone.0059628-Wargovich1], [@pone.0059628-VanderMeer1]. This activity can protect epithelial cells from mutagens in the colon. In addition, calcium is involved in intracellular mechanisms that affect cell proliferation and differentiation [@pone.0059628-Lipkin1], [@pone.0059628-Lapre1], and calcium decreases epithelial cell proliferation directly [@pone.0059628-Buset1].

*CASR* has been implicated in mediating the anticarcinogenic effects of calcium on colorectal cancer [@pone.0059628-Kallay1], [@pone.0059628-Chakrabarty1], [@pone.0059628-Kallay2], [@pone.0059628-Lamprecht1]. *CASR* expression is detected in both the basolateral and luminal surfaces of the colon, implying that this gene is involved in the pathway that regulates the calcium concentration in the colon and in the blood [@pone.0059628-Lamprecht1], [@pone.0059628-Chattopadhyay1], [@pone.0059628-Cheng1]. According to a review describing the *CASR* molecular pathway in colorectal cancer [@pone.0059628-Lamprecht1], calcium activates certain signalling pathways that participate in cell growth and differentiation via *CASR*, including the promotion of E-cadherin expression and the suppression of β-catenin and T-cell factor activation, as well as the activation of the p38 mitogen-activated protein kinase cascade [@pone.0059628-Hobson1]. In addition, laboratory results suggested that CASR might mediate the pro-cell proliferative effects of low intestinal calcium concentration [@pone.0059628-Kallay1], [@pone.0059628-Kallay2].

The results of the current study showed that *CASR* polymorphisms themselves were not likely to be correlated with colorectal cancer. This is consistent with previous observational studies that demonstrated no association between *CASR* polymorphisms and colorectal cancer [@pone.0059628-Dong1], [@pone.0059628-Jenab1], although several studies have reported significant associations between SNPs in *CASR* and colorectal cancer risk [@pone.0059628-Speer1], [@pone.0059628-Jacobs1], [@pone.0059628-Bacsi1]. The SNPs that were included in this study, *rs10934578*, *rs12485716*, *rs2270916*, and *rs4678174*, were not associated with overall colorectal cancer in previous studies, although *rs12485716* and *rs2270916* were associated with proximal colon cancer risk [@pone.0059628-Dong1]. These associations with proximal colon cancer were not replicated in our study. *Rs4678174* was demonstrated to have no relationship with colorectal cancer in two studies that were performed in European [@pone.0059628-Jenab1], North American, and Australia [@pone.0059628-Jacobs1] populations, respectively. This study could serve as further evidence from an Asian population.

We did not find any overall interaction effects between *CASR* polymorphisms and daily calcium intake on colorectal cancer. However, among patients with the same *CASR* genotypes, subjects with lower calcium intake showed higher colorectal cancer risk than did subjects with higher calcium intake. To date, no major studies have demonstrated interaction effects between calcium intake and *CASR* polymorphisms on colorectal cancer. Previous studies that analysed interaction effects between calcium intake and *CASR* polymorphisms noted no associations with colorectal cancer [@pone.0059628-Dong1], [@pone.0059628-Jenab1]. Our results are generally consistent with those null associations; however, we noticed a meaningful increase in colorectal cancer risk in the low calcium intake group compared to the high calcium group after stratification by *CASR* risk genotype. Though further study is required to fully understand how dietary calcium and *CASR* interact to modulate colorectal cancer carcinogenesis, our observations suggest that individuals who have low dietary calcium intake should be aware of their colorectal cancer risk and prevention strategies.

Our study has several limitations. Because we used cancer examination screenees as controls, they might be healthier than the general population, although they were recruited from the hospital. In addition, to minimize the potential information bias between groups, the interviewer who was in charge of data collection from the food frequency questionnaire for cases was also involved in the survey for controls. We included only 4 SNPs within the *CASR* in our investigation of the gene-only and gene-environment interaction effects on colorectal cancer. To evaluate the effects of *CASR* polymorphism and calcium intake on colorectal cancer, further studies which include more SNPs on *CASR* would be required. The criterion used for calcium intake is another limitation of our study. Grouping of calcium intake was based on average intake value of study population, not recommended dietary allowances (RDA) for Korean population. However, because our calcium intake criterion was lower than the RDA [@pone.0059628-The1], we could conclude that lower calcium intake was likely to be a risk factor for colorectal cancer.

In conclusion, we demonstrated that there is an increased risk of colorectal cancer in subjects with low calcium intake and *CASR* polymorphisms. Further investigations will be required to explain the genetic and gene-environmental effects on colorectal cancer in larger sample sizes and using additional *CASR* functional regions or variants. Increasing the calcium intake to the DRI level is recommended to prevent colorectal cancer in Korea.
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